Cholesterol esters in 20 IJ.I of plasma are hydrolysed with hot ethanolic KOH. Preformed cholesterol and cholesterol released by hydrolysis is reacted with cholesterol oxidase to form hydrogen peroxide and cholest-4-en-3-one, which is extracted from alkaline 50 %vIv ethanolic solution with iso-octane. The absorbance of the ketone in iso-octane at the 232 nm peak is used to measure the cholesterol originally present. Plasma blanks obtained by omitting the cholesterol oxidase from the reagent show negligible absorbance even when the samples are grossly icteric, lipaemic, or haemolysed. The test is carried out in a single glass screw-capped tube, and the absorbance given by a sample containing 6·25 mmol/l cholesterol is = 0'44, corresponding to a molar absorbance of = 17 500. The conversion of cholesterol to cholest-4-en-3-one is stoichiometric, and the absorbance of the iso-octane layer is stable for at least 48 hours. A single determination occupies 30 minutes; 30 samples can be analysed in It hours.
+ H 2 0 + Esterase hydrolysis has the disadvantage that 02~H202 + cholest-4-en-3-one,· some cholesterol esters are not easily hydrolysed, and have been introduced for the determination of this is particularly true of some control materials containing added cholesterol esters. plasma cholesterol. Usually the hydrogen peroxide is Interfering substances in direct coupling reactions determined by using one of the many coupling reactions whereby a dye is produced in the system can cause negative or positive errors. Negative errors can be caused by the presence of reducing substances H 20 2 + peroxidase + chromogen~coloured such as bilirubin, uric acid. or ascorbic acid, which product + H 20 . . may interfere by destroying hydrogen peroxide before These coupling systems have been shown to be it can take part in the coupling reaction, or by reliable for the determination of hydrogen peroxide reduction of the final coloured product to less formed by glucose in the glucose oxidase reaction, if highly coloured or colourless derivatives. Negative proteins are removed by dialysis or precipitation. errors can also be caused by failure of the reagents Cholesterol, however, cannot be separated from completely to release cholesterol from lipoprotein protein in aqueous solution. As cholesterol is present complexes or by substances which interfere with the in plasma mainly as esters, these must be hydrolysed coupling reaction itself. before the oxidase reaction can take place. The Positive errors arise from the presence of highly preliminary isolation of cholesterol by saponification coloured compounds, such as bilirubin or haemoand petroleum spirit extractions 4 or by precipitation globin, or from oxidising reagents. Lipaemia is also a with digitonin, 6 used in a number of non-oxidase cause of positive interference. methods for plasma cholesterol determination, has
The extent of the interferences will depend on the not found favour with modem investigators, and the formulation of the reaction mixture, particularly attraction of a direct reaction using dilute plasma has with regard to pH, surfactant and enzyme coneenbeen preferred in spite of the possible disadvantages tration, the wavelength at which the readings are of such an approach. In these direct methods taken, and the nature of the coupling reaction used. 64
Bilirubin appears to be unique in that it can cause negative interference by oxidation to biliverdin, or positive interference due to its high colour if unoxidised. The presence of cholesterol analogues such as cholest-5 :7-dien-3~ol (7-dehydrocholesterol) , which form hydrogen peroxide in the cholesterol oxidase reaction, may also cause positive interference.
Most direct methods do not use a plasma blank correction and this at least partially compensates for negative interference. Overall the reasonably accurate results given by direct coupling methods are due to a combination of negative and positive errors, or to the use of a serum setting standard with an assigned cholesterol value chosen to give satisfactory results with patients' plasma samples. The assigned value may differ considerably from the true cholesterol content of the setting serum.
A more logical approach to the determination of plasma cholesterol would be to utilise the properties of cholest-4-en-3-one, which is produced along with hydrogen peroxide in the oxidase reaction. Cholest-4en-3-one has a molar absorbance of about 16 ()()() in aqueous solution at the peak at 240 nm. It is much more stable in solution than the dyes produced in hydrogen peroxide coupling reactions and it can be obtained commercially. It is therefore an ideal substance for the study of the stoichiometry of the cholesterol oxidase reaction, and the possibility of using its properties in a method for the determination of plasma cholesterol is attractive.
Experimental
After ethanolic potassium hydroxide hydrolysis, plasma cholesterol can be quantitatively extracted from 50-60% vlv ethanol/water solutions using petroleum spirit. 3 40 Cholest-4-en-3-one extracts similarly but petroleum spirit has a relatively high absorbance at 232 nm, the absorbance peak of the ketone. 2:2:4 Tri-methyl pentane (iso-octane) was found to be an ideal alternative to petroleum spirit as it also extracts the ketone quantitatively and it has a very low absorbance at wavelengths longer than 225 nm. Cholest-4-en-3-one has a molar absorbance of~17 500 at the absorbance peak when extracted into iso-octane.
The absorbance of cholest-4-en-3-one in iso-octane can be measured only if the reagents used are free from extractable substances which have a high absorbance at 232 nm. Some of the wetting agents used to accelerate the conversion of cholesterol to cholest-4-en-3-one are therefore unsuitable for examination. This is true particularly of Triton X_1OO (iso-octyl phenoxypolyethoxy ethanol containing~10 mols ethylene oxide), which is a very efficient wetting agent but which has a very high absorbance at 232 nm when extracted into iso-octane. Other surfactants such as sodium cholate are less effective in assisting in the conversion of cholesterol to its ketone. The most suitable commerically available cholesterol oxidase reagent (Boehringer Corporation (London) Ltd) contains 'hydroxypolyethoxy dodecane' as surfactant, and this reagent was used in the initial experimental work.
Plasma, cholesterol, and cholesterol hemisuccinate solutions were heated with ethanolic potassium hydroxide followed by reaction with cholesterol oxidase and extraction into iso-octane. Under suitable conditions stoichiometric conversion of cholesterol and cholesterol hemisuccinate to cholest-4-en-3-one was achieved. Plasma gave a yield of the ketone in close agreement with that expected from the cholesterol content as determined by the saponification/petroleum spirit extraction/acetyl chloride method of Trinder.' The acetyl chloride method agrees closely with the well-established digitonin precipitation/Liebermann-Burchard procedure of Sperry and Webb. 5 Iso-octane is required as a solvent to remove substances which absorb at 232 nm in aqueous solution but which are insoluble in the organic solvent.
Since the formulation of the commercial reagent could be altered by the manufacturer, a brief study was made of a number of polyethoxylated linear alcohols as alternatives to 'hydroxy polyethoxy dodecane'. Texofor V27 and Lutensol ON70 D were found to be superior to 'hydroxypolyethoxy dodecane' as wetting agents, Lutensol ON70 D being the most effectivesurfactant.
Based on the above work, a convenient method for the determination of plasma cholesterol was worked out. (a) For total cholesterol determination: 125 nmol/ tube. Dilute 5 ml of the stock solution to 250 ml with petroleum spirit BP 4O-60 oC. Transfer 1 ml quantities of this dilution to 12 ml screw-capped tubes. Remove the solvent by placing the tubes in a bath of boiling water. Cap the tubes and store them at 4°C. The dried standards keep for at least one year. (b) For HDL cholesterol determination: 75 nrnol/l tube. Dilute 3 ml of the stock solution to 250 ml with petroleum spirit BP 40-60 oC. Transfer 1 ml quantities of this dilution to 12 ml screw-capped tubes. Remove the solvent and store as for total cholesterol. Procedure TOTAL CHOLESTEROL In a 12 ml screw-capped tube labelled T(est) place 20 fLl plasma. To T, to a S(tandard) tube containing 125 nmol cholesterol, and to an empty tube labelled B(lank) add 200 fLl ethanolic KOH. Mix the contents of the tubes by gentle to and fro shaking. Tightly cap the tubes to prevent loss of ethanol and place them in a bath of briskly boiling water.
Method
After 2 minutes cool the tubes and add 2 ml working oxidase (a) or (b) . Mix and incubate the tubes in a water bath at 50°C. After 15 minutes add 1· 8 ml ethanolic KOH to each tube, followed by 5 ml iso-octane. Cap the tubes tightly and shake them vigorously for 1 minute. Spin the tubes briefly to separate the liquid layers. Read the absorbance of the iso-octane (upper) layer of Sand T against B. Cells quartz lOmm light path; wavelength 232 nm (peak).
Total plasma cholesterol Absorbance ofT '( 6.25 (mmol/litre) Absorbance ofS ' If the absorbance of T is greater than O'7 repeat the analysis using an appropriate dilution of the sample. If a scanning spectrophotometer is used, set the scan between 300 and 225 nm and take the reading at the absorbance peak. Cholest-4-en-3-one does not absorb at 300 nm and the absorbance of tests and standard should not exceed 0·005 at this wavelength. The spectrophotometer used should be checked for wavelength accuracy. The absorbance of Sat 232 nm should be 0'42--0'44, corresponding to molar absorbances of 16 800-17 600. The absorbance of the iso-octane layer does not alter on standing for 48 hours over the alkaline ethanolic subnatant mixture. B read against iso-octane has an absorbance of about 0·005--0·015 at 232 nm. Cholesterol (mmol/litre) investigated and they appear to give complete extraction of cholesterol from plasma. The ethanol extraction method is also claimed to give complete extraction, but preliminary experiments indicated that only 98 %of cholesterol is recovered from plasma. Using the three extraction methods, I ml quantities of extract containing the equivalent of 20 fl.1 plasma were dried, and the proposed method was used to determine the cholesterol in the residue. The iso-octane method applied directly to 20 fl.1 plasma gave the same mean results as the petroleum spirit and ethanol/acetone extraction systems, but the ethanol extraction system gave somewhat lower results (Table 3) .
Plasma blanks obtained by putting samples through the whole procedure, but substituting blank reagent for working oxidase reagent, gave negligible readings. Sixty successive samples from the routine intake gave a mean absorbance of 0'000 at 232 nm, range -0'004 to +0·005. These samples included grossly lipaemic, grossly icteric, and grossly haemolysed specimens. Within-and between-batch precision for plasma samples indicates satisfactory performance by the method ( Table 1 ). The proposed method was compared with the acetyl chloride methods and close agreement was found (Table 2) . Studies were carried out using the proposed method applied to three methods of extracting cholesterol from plasma. The three extraction methods chosen were (i) saponification/petroleum spirit, 4 (ii) ethanol," and (iii) ethanol/acetone." The petroleum spirit and ethanol/ acetone extraction methods have been extensively
Results

HDL CHOLESTEROL
The procedure is the same as for total cholesterol, but 50 fl.1 of prepared sample is taken for analysis, 3 ml iso-octane is used to extract the cholest-4-en-3one, and a tube containing 75 runol cholesterol is used as the standard. All other quantities are as for total cholesterol. HDL cholesterol in the Absorbance ofT x i-5 prepared sample (rnrnol/litre) Absorbance ofS This result must be multiplied by the dilution factor introduced in preparing the sample for analysis. This method has been used with phosphotungstic acid/magnesium chloride HDL preparations. It has not been used with heparin/manganese sulphate preparations. 
along with cholesterol, and as these derivatives will react with the Liebermann-Burchard reagent, it follows that the non-cholesterol sterols in plasma must amount to less than 1% of the total sterols determined as cholesterol in the method of Abell et af.3
The evidence for the presence of relatively large amounts of 7-dehydrocholesterol in plasma is based on the work of Koehler and Hill," which has been widely quoted by other authors. Koehler and Hill assumed that a plasma sterol giving a 'fast' reaction with a Liebermann-Burchard reagent was 7-dehydrocholesterol. This finding is probably due to an artefact, since Sobel et al.,!0 in a careful study using UV spectrophotometry, found only 0·009-{)·020 mmoljl, mean 0·013 mmoljl, in 12 plasma samples. Since the UV method itself is not specific, the true concentration of 7-dehydrocholesterol in plasma is probably lower than the figures given by Sobel et 01. 10 Since the discrepancy between the findings of Sobel et al, and Koehler and Hill was so marked, a study was made of the concentration of 7-dehydrocholesterol in 20 successive plasma samples from the routine intake. 7-dehydrocholesterol has a characteristic UV absorption spectrum with strong peaks at 260, 270, 282, and 294 nm. The peak at 282 nm has a molar absorbance of 10700, and this affords a sensitive method for the determination of the sterol. 200 ILl plasma was saponified with 2 mI ethanolic potassium hydroxide, and the sterols were extracted into 5 mI iso-octane after the addition of 1· 8 m1 water. At a level of O'5 rnmol/l plasma 7-dehydro-. cholesterol, the expected absorbance at 232 nm using lOmm cells would be 0·215. In fact all the absorbances were less than 0'01, equivalent to plasma levels of less than 0·025 mmol/l, confirming the findings of Sobel et al.
The cholesterol equivalents of three cholesterol analogues were determined using the proposed method and the acetyl chloride method! (Table 4 ). Since the cholesterol equivalent of 7-dehydrocholesterol is 53 %, the error in the proposed method due to its presence will be 0·01 mmol/l of plasma, or less. Cholest-7-en-3~-01 and dihydrocholesterol will oxidise to cholest-7-en-3-one and cholestan-3-one respectively. Neither of these ketones will absorb in the ultraviolet as they lack conjugated double bonds.
Dihydrocholesterol is available commerically, and the negligible absorbance of its ketone was confirmed in the present study (Table 4 ). Cholest-J-en-Sf -01 was not available for study, but Munster et 01. 11 examined this compound and found that it had a cholesterol equivalent of 16% when converted to its ketone by cholesterol oxidase. Munster et al. were unable to explain this finding, but it is possible that their sample of cholest-7-en-3~-01 was impure and contained other sterols. In any case, if the cholesterol equivalent of cholest-r-en-Jp-ol is 16%, the error in the proposed method would be only 0·013 mmoljl, assuming a mean plasma level of O'08 mmol/l.
Discussion and conclusion
The idea is widely held that a method employing a relatively specific enzyme will give more accurate results than one using ordinary chemical reactions. This is true only if the method used to measure the products of the reaction is also specific. There is no reason to suppose that the determination of hydrogen peroxide by coupling reactions carried out directly on plasma/cholesterol oxidase mixtures is any more specific than the determination using Liebermann-Burchard type reactions. In fact methods involving the preliminary isolation of cholesterol by petroleum spirit extraction, or by digitonin precipitation, followed by chemical colour reactions are probably more specific than direct colour coupling oxidase methods. The proposed method, particularly the version employing a blank correction, determines the accuracy of other methods, particularly automated methods employing a serum setting standard with an assigned value. Analysing the serum setting standard using the proposed method will give only the accurate cholesterol content of the serum, and this may be different from the assigned value used to give reasonably accurate results with patients' plasma samples. ' The proposed method should be used in the following way. A patient's plasma sample or samples from several patients should be analysed, preferably in duplicate, by the method being investigated and by the proposed method. If the assigned value is correct, results given by the two methods will agree. If the setting serum is also analysed by the proposed method, the degree of stoichiometry of the method being investigated will be determined. only cholesterol derivatives capable of being converted by cholesterol oxidase to UV-absorbing ketones. From the present study and from published data it is unlikely that interfering substances exceed 0·05 mmol/l in subjects not undergoing drug therapy, and in fact the error is probably less than this.
Drug therapy could cause inaccuracies in the proposed method in two ways. The drug involved could be extracted into iso-octane giving high blank values. The use of a blank correction eliminates this type of interference. The results of successive blank tests on a wide variety of samples indicates that direct interference from drugs is unlikely to be a problem, but the possibility of drug interference should be borne in mind.
Drug therapy may also result in the production of cholesterol derivatives. MER 29 (triparanol) administration results in the appearance of substantial amounts of cholest-5 :24-dien-3~-01 (desmosterol) in the plasma.P This derivative can be expected to oxidise to cholest-4:24-dien-3-one having a similar absorbance to cholest-4-en-3-one. Desmosterol was not available for examination but it is likely that the proposed method will include it in the total cholesterol value. In fact any 3[j-sterol with double bonds in the 4/5 or 5/6 positions will be converted by cholesterol oxidase to ketones which will absorb in the ultraviolet if conjugated double bonds are present.
Cholesterol oxidase reagents containing Lutensol ON70 D or Texofor V27 are also suitable for the determination of cholesterol in aqueous solution at 240 nm, after preliminary isolation by saponification and petroleum spirit extraction of plasma, but the one tube method proposed has been preferred as the only critical volume measurements are the 20 !Ll of sample and the 5 ml of iso-octane used. Lutensol ON70 D is very active in promoting the action of cholesterol esterase, and the possibility of determining plasma cholesterol directly in aqueous solutions at 240 nm is being investigated. The rather high blanks shown by diluted plasma at 240 nm make it difficult to use such a method for routine purposes, but as an alternative to the proposed iso-octane method it might be suitable as a reference method.
The application of the proposed method to continuous-flow systems has not been achieved as iso-octane dissolves UV-absorbing substances from the plastic pump tubing, but the possibility of avoiding this problem is being investigated.
The proposed method can be used for the routine determination of plasma cholesterol. A single determination occupies 30 minutes, and 30 samples can be analysed in Ii hours. The method may have its best application as a reference method to check on
